Sun Pharmaceuticals reported INR97.71B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Aspen Pharmacare ZAR 5.62B 789M Dec/2025
Bharat Petroleum INR 3.2B 134.24B Mar/2026
Cipla INR 10.18B 2.22B Mar/2026
Dr.Reddys Laboratories INR 11.2B 4.16B Jun/2026
Jiangsu Hengrui CNY 40.96B 591.41M Dec/2025
Sh Fosun Pharma CNY 13.1B 1.63B Dec/2025
Sun Pharmaceuticals INR 97.71B 15.61B Mar/2026
UPL INR 59.75B 18.23B Mar/2026